Metadate Cd

Narcolepsy, Attention Deficit Hyperactivity Disorder

Treatment

20 Active Studies for Metadate Cd

What is Metadate Cd

Methylphenidate

The Generic name of this drug

Treatment Summary

Methylphenidate is a stimulant medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy. It is sold under the brand names Ritalin, Concerta, and Biphentin and is typically used with other therapies such as psychological, educational, and cognitive behavior therapy to improve symptoms like distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. Methylphenidate works by increasing the presence of norepinephrine and dopamine in the brain. It is generally safe and effective and can be prescribed to both adults and children. However, it has

Methylphenidate Hydrochloride

is the brand name

image of different drug pills on a surface

Metadate Cd Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Methylphenidate Hydrochloride

Methylphenidate

1955

490

Effectiveness

How Metadate Cd Affects Patients

Methylphenidate is a drug that contains two different components, the d- and l-isomers. The d-isomer is more effective than the l-isomer in producing its effects. Studies have shown that it binds to dopamine-rich areas of the brain, especially in the prefrontal cortex, which is involved in ADHD. In animals, methylphenidate has been shown to increase physical activity and cause repetitive behaviors.

How Metadate Cd works in the body

Methylphenidate works by increasing the amount of norepinephrine and dopamine in the brain. This can help improve attention and memory, which is especially beneficial for people with ADHD. It is believed that methylphenidate helps by filling the gaps caused by genetic abnormalities in the dopamine transporter gene, D4 receptor gene, and D2 receptor gene. Higher doses increase activity throughout the brain, while lower doses more selectively target the prefrontal cortex, which is important for ADHD. Additionally, methylphenidate's abilities to reduce impulsivity and movement are due to its effects on alpha-1 adrenergic receptors.

When to interrupt dosage

The proposed measure of Metadate Cd is contingent on the recognized affliction. The amount of dosage fluctuates, as per the technique of delivery specified in the table below.

Condition

Dosage

Administration

Attention Deficit Hyperactivity Disorder

20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release, Suspension, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral

Narcolepsy

20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release, Suspension, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral

Warnings

Metadate Cd has fourteen contraventions, so it should not be blended with any of the conditions shown in the below table.

Metadate Cd Contraindications

Condition

Risk Level

Notes

advanced arteriosclerosis

Do Not Combine

Gilles de la Tourette syndrome

Do Not Combine

Thyrotoxicosis

Do Not Combine

Pulse Frequency

Do Not Combine

Open-angle glaucoma

Do Not Combine

Hypertensive disease

Do Not Combine

Pulse Frequency

Do Not Combine

Tension-Type Headache

Do Not Combine

Generalized Anxiety Disorder

Do Not Combine

symptomatic cardiovascular disease

Do Not Combine

Tourette Syndrome

Do Not Combine

Pheochromocytoma

Do Not Combine

Tics

Do Not Combine

Agitation

Do Not Combine

There are 20 known major drug interactions with Metadate Cd.

Common Metadate Cd Drug Interactions

Drug Name

Risk Level

Description

Desflurane

Major

Methylphenidate may increase the hypertensive activities of Desflurane.

Diethyl ether

Major

Methylphenidate may increase the hypertensive activities of Diethyl ether.

Enflurane

Major

Methylphenidate may increase the hypertensive activities of Enflurane.

Halothane

Major

Methylphenidate may increase the hypertensive activities of Halothane.

Isoflurane

Major

Methylphenidate may increase the hypertensive activities of Isoflurane.

Metadate Cd Toxicity & Overdose Risk

Overdosing on amphetamine can lead to symptoms such as vomiting, restlessness, trembling, increased reflexes, muscle spasms, seizures, feeling very good, confusion, seeing or hearing things that aren't real, restlessness, heavy sweating, flushed skin, headache, extreme body temperature, rapid heartbeat, abnormal heart rhythms, high blood pressure, wide open pupils, and dry mouth. The lowest toxic dose in mice is 190mg/kg when taken orally.

image of a doctor in a lab doing drug, clinical research

Metadate Cd Novel Uses: Which Conditions Have a Clinical Trial Featuring Metadate Cd?

84 active clinical studies are being conducted to assess the effectiveness of Metadate Cd in treating Attention Deficit Hyperactivity Disorder.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

63 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2

Narcolepsy

2 Actively Recruiting

Not Applicable, Phase 1

Metadate Cd Reviews: What are patients saying about Metadate Cd?

5

Patient Review

12/8/2013

Metadate Cd for Attention Deficit Disorder with Hyperactivity

We've noticed a significant decline in the effectiveness of this medication since switching to the generic brand. Has anyone else experienced this? We'd love to hear any suggestions.

4.7

Patient Review

1/5/2012

Metadate Cd for Attention Deficit Disorder with Hyperactivity

I have found that this drug works best for my kids, one with ADD and the other with ADHD and autism. I know it's also called Ritalin, but Metadate CD is released into the brain differently than Ritalin and doesn't have nearly as many side effects. I've been a very happy parent with this drug because it has gotten my son into the gifted program at school. It helps him focus and concentrate easier. He is very smart and gets along with all different kinds of kids.

4.3

Patient Review

9/5/2012

Metadate Cd for Attention Deficit Disorder with Hyperactivity

I've found that 30mg of Metadate twice a day works really well for me. I'm able to stay focused and haven't had any issues with appetite loss, which I've experienced with other medications.

4.3

Patient Review

8/9/2013

Metadate Cd for Attention Deficit Disorder with Hyperactivity

I've been taking this drug for years and it's helped me a lot. I'm more calm and focused, which has been great for school and other tasks. I do get some side effects from the medication, but nothing that's too bad or unmanageable.

4

Patient Review

3/17/2013

Metadate Cd for Attention Deficit Disorder with Hyperactivity

My daughter has been taking Metadata CD 30mgs for the last year. It works great. U can tell when it kicks in and when it wears off, usually around 4:30 it's very hard for her to do homework independently.

4

Patient Review

2/12/2015

Metadate Cd for Attention Deficit Disorder with Hyperactivity

My son was on this medication for nearly two years. Last year, he developed very low white blood cells and began having mouth sores once or twice a month from January to November. In December, I decided to take him off the medication; his health improved immediately. Otherwise, this medication worked perfectly for him.

4

Patient Review

6/4/2014

Metadate Cd for Attention Deficit Disorder with Hyperactivity

We've seen such a significant difference in our child's behavior since starting this treatment. The whole family is thrilled!

4

Patient Review

2/14/2017

Metadate Cd for Attention Deficit Disorder with Hyperactivity

I've been taking this drug for nine years, since I was nine. It's effective but there is a chance of long-term brain damage that causes depression and schizophrenia like symptoms. I'm experiencing those now.

3.7

Patient Review

9/21/2012

Metadate Cd for Attention Deficit Disorder with Hyperactivity

My 12 year old daughter has been on Metadate 40 mg one per day for about 3 months and it seems to work well for her. We are still experiencing days when she isn't able to sit still or stop talking (most of the time jumping from one subject to the next,without finishing).

3

Patient Review

8/8/2012

Metadate Cd for Attention Deficit Disorder with Hyperactivity

I felt more energetic and focused after taking this treatment.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about metadate cd

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Metadate CD the same as Ritalin?

"Metadate CD can improve focus and decrease impulsivity and hyperactivity for some patients with the condition. It contains the same active ingredient as medications like Ritalin and Daytrana."

Answered by AI

What does Metadate CD mean?

"Metadate CD is a drug used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. It is a central nervous system (CNS) stimulant."

Answered by AI

What is the difference between Metadate CD and ER?

"The difference between Metadate CD and Metadate ER is that Metadate CD is a once-a-day capsule with biphasic release while Metadate ER is a tablet given two to three times per day. Metadate ER may be titrated to eliminate the need for midday dosing."

Answered by AI

Has Metadate CD been discontinued?

"The brand name Metadate CD has been discontinued by the manufacturer and is no longer available. All brand name Metadate CD National Drug Codes have been terminated by the Centers for Medicare and Medicaid Services."

Answered by AI

Clinical Trials for Metadate Cd

Image of Seattle Children's Hospital in Seattle, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Seattle, WA

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Seattle Children's Hospital

Image of St. Jude Children's Research Hospital in Memphis, United States.

Methylphenidate for Sickle Cell Disease

8 - 17
All Sexes
Memphis, TN

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study will assess any thinking or attention problems participants may have both before taking this drug and after. Additionally, the study will assess the decision-making process of the caregiver that may influence using this drug or not. Primary Objective: • Assess the feasibility, acceptability, and adherence to MPH treatment in children with SCD and EF deficits. Secondary Objective: • Evaluate neurobehavioral and safety outcomes following MPH treatment. Exploratory Objective: • Evaluate decision-making and determinants influencing methylphenidate utilization among parents.

Phase 1
Recruiting

St. Jude Children's Research Hospital

Andrew Heitzer, PhD

Have you considered Metadate Cd clinical trials?

We made a collection of clinical trials featuring Metadate Cd, we think they might fit your search criteria.
Go to Trials
Image of The University of Iowa in Iowa City, United States.

fMRI for Cognitive Flexibility

18 - 35
All Sexes
Iowa City, IA

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Waitlist Available
Has No Placebo

The University of Iowa

Image of UCSF Nancy Friend Pritzker Psychiatry Building in San Francisco, United States.

Trigeminal Nerve Stimulation for ADHD in Children with Autism

7 - 14
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Recruiting
Device

UCSF Nancy Friend Pritzker Psychiatry Building

Image of The University of Texas at Austin in Austin, United States.

Transcranial Photobiomodulation for ADHD

18 - 44
All Sexes
Austin, TX

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Waitlist Available
Online Trial

The University of Texas at Austin

Have you considered Metadate Cd clinical trials?

We made a collection of clinical trials featuring Metadate Cd, we think they might fit your search criteria.
Go to Trials
Image of Louisiana State University in Baton Rouge, United States.

Virtual Reality for ADHD

18 - 25
All Sexes
Baton Rouge, LA

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Phase 4
Waitlist Available

Louisiana State University (+1 Sites)

Joshua M Langberg, PhD

Image of Duke University in Durham, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Durham, NC

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Duke University

John Mitchell, PhD

Image of Kennedy Krieger Institute in Baltimore, United States.

Iron Supplementation for ADHD and Restless Sleep

8 - 18
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment

Phase 1 & 2
Waitlist Available

Kennedy Krieger Institute

Alison E Pritchard, PhD

Image of Montana State University in Bozeman, United States.

Speech-Gesture Combinations for Autism

Any Age
All Sexes
Bozeman, MT

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Recruiting
Has No Placebo

Montana State University

Have you considered Metadate Cd clinical trials?

We made a collection of clinical trials featuring Metadate Cd, we think they might fit your search criteria.
Go to Trials